← PHIBRO ANIMAL HEALTH CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $751.5m |
$764.3m
+1.70%
|
$820.0m
+7.29%
|
$828.0m
+0.98%
|
$800.4m
-3.34%
|
$833.4m
+4.12%
|
$942.3m
+13.07%
|
$977.9m
+3.78%
|
$1.0b
+4.07%
|
$1.3b
+27.37%
|
$1.5b
+15.72%
|
|
| Cost of Revenue | $512.5m |
$516.0m
+0.69%
|
$553.1m
+7.18%
|
$563.4m
+1.86%
|
$543.5m
-3.53%
|
$562.0m
+3.40%
|
$656.9m
+16.88%
|
$679.7m
+3.47%
|
$704.6m
+3.67%
|
$896.3m
+27.21%
|
$1.0b
+12.90%
|
|
| Cost of goods sold | — | — | $553.1m |
$563.4m
+1.86%
|
$543.5m
-3.53%
|
$562.0m
+3.40%
|
$656.9m
+16.88%
|
$679.7m
+3.47%
|
$704.6m
+3.67%
|
($896.3m)
-227.21%
|
$1.0b
+212.90%
|
|
| Gross Profit | $239.0m |
$248.2m
+3.85%
|
$266.9m
+7.51%
|
$264.6m
-0.84%
|
$256.9m
-2.93%
|
$271.4m
+5.64%
|
$285.4m
+5.17%
|
$298.2m
+4.50%
|
$313.1m
+4.98%
|
$399.9m
+27.74%
|
$488.1m
+22.05%
|
|
| Interest Income (Expense), Net | ($16.6m) |
($14.9m)
+10.16%
|
($11.9m)
+20.10%
|
($11.8m)
+1.13%
|
($12.9m)
-9.17%
|
($12.9m)
-0.19%
|
($11.9m)
+7.80%
|
($15.3m)
-29.02%
|
— | — | $1.9m | |
| Research and Development Expense | $11.0m | $9.4m | $10.0m | $12.1m | $13.7m | $17.8m | $20.8m | $24.4m | $29.2m | $23.7m | — | |
| Selling, General and Administrative Expense | $153.3m | $150.3m | $168.0m | $181.4m | $187.7m | $196.5m | $206.4m | $226.4m | $259.8m | $289.5m | $308.2m | |
| Amortization of Intangible Assets | $5.6m | $6.0m | $5.9m | $6.1m | $8.9m | $8.7m | $8.9m | $9.7m | $9.7m | $7.8m | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | $85.7m |
$97.9m
+14.22%
|
$98.9m
+1.01%
|
$83.2m
-15.87%
|
$69.2m
-16.86%
|
$74.9m
+8.20%
|
$79.0m
+5.50%
|
$71.8m
-9.04%
|
$53.3m
-25.79%
|
$110.5m
+107.19%
|
$180.0m
+62.91%
|
|
| Interest Expense | — | — | — | — | $14.6m | $13.7m | $12.7m | $18.7m | — | — | $42.4m | |
| Interest Expense, Debt | $16.8m | $16.9m | $13.6m | $13.7m | — | — | — | — | — | — | $42.4m | |
| Interest expense, net | — | — | $11.9m | $11.8m | $12.9m | $12.9m | $11.9m | $15.3m | $18.5m | $34.6m | $42.4m | |
| Foreign Currency Transaction Gain (Loss), before Tax | $7.6m | $113k | $1.1m | $55k | ($826k) | $4.5m | $5.2m | ($2.5m) | ($23.9m) | ($7.9m) | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | — | $899k | $2.9m | — | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | ($1.7m) | $0 | $0 | — | — | — | — | ($10.7m) | — | — | |
| Interest and Other Income | ($256k) | $2.0m | $1.7m | $1.9m | $1.8m | $838k | $816k | $3.4m | $4.5m | $2.6m | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $23.0m | $37.2m | $42.4m | |
| Interest Income (Expense), Nonoperating, Net | $16.6m | $14.9m | ($11.9m) | $11.8m | ($12.9m) | ($12.9m) | ($11.9m) | ($15.3m) | ($18.5m) | ($34.6m) | $1.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $2.0m | $18.0m | $19.8m | $2.3m | ($3.1m) | $12.7m | $27.7m | $14.8m | ($22.8m) | $3.3m | $128.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $76.8m | $80.5m | $88.1m | $71.5m | $55.5m | $66.5m | $72.3m | $54.1m | $10.9m | $68.0m | $128.9m | |
| Provision for income taxes | $6.0m | $15.9m | $23.2m | $16.8m | $22.0m | $12.1m | $23.2m | $21.5m | $8.5m | $19.7m | — | |
| Current Income Tax Expense (Benefit) | $16.8m | $15.9m | $17.1m | $16.2m | $13.8m | $14.3m | $24.0m | $24.4m | $20.5m | $24.5m | $33.6m | |
| Net Income (Loss) Attributable to Parent | $82.7m |
$64.6m
-21.89%
|
$64.9m
+0.41%
|
$54.7m
-15.67%
|
$33.6m
-38.68%
|
$54.4m
+62.09%
|
$49.2m
-9.58%
|
$32.6m
-33.69%
|
$2.4m
-92.59%
|
$48.3m
+1897.68%
|
$95.2m
+97.32%
|
|
| Earnings Per Share, Basic | $2.11 | $1.63 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | $2.34 | |
| Earnings Per Share, Diluted | $2.07 | $1.61 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | $2.33 | |
| Common Stock, Dividends, Per Share, Declared | $0.40 | $0.40 | $0.40 | $1.35 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | — | |
| basic (in shares) | 39.3m | 39.5m | $40k | $40k | $40k | $40k | $40.5m | $40.5m | $40.5m | $40.5m | $40.5m | |
| diluted (in shares) | 40.0m | 40.0m | $40k | $41k | $41k | $41k | $40.5m | $40.5m | $40.5m | $40.7m | $40.9m | |
| Weighted Average Number of Shares Outstanding, Basic | 39.3m | 39.5m | 40k | 40k | 40k | 40k | 40.5m | 40.5m | 40.5m | 40.5m | 40.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 40.0m | 40.0m | 40k | 41k | 41k | 41k | 40.5m | 40.5m | 40.5m | 40.7m | 40.9m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $1.7m | $1.7m | $1.2m | $0 | — | — | — | — | — | — | — | |
| Capitalized Computer Software, Amortization | — | — | $1.5m | $1.2m | $1.0m | $1.3m | $1.0m | $1.5m | $1.4m | $1.4m | — | |
| Foreign currency losses, net | ($7.6m) | — | ($1.1m) | ($55k) | $826k | ($4.5m) | ($5.2m) | $2.5m | $23.9m | $7.9m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.